Literature DB >> 16614808

Isoflurane therapy for severe refractory status asthmaticus in children.

Venkat Shankar1, Kevin B Churchwell, Jayant K Deshpande.   

Abstract

OBJECTIVE: To describe the use of inhaled isoflurane in a series of children with life-threatening asthma.
DESIGN: Retrospective case series.
SETTING: Pediatric intensive care unit of a tertiary-care children's hospital. Ten children ranging in age from 1 to 16 years with 11 episodes of severe asthma requiring invasive mechanical ventilation in the pediatric intensive care unit over a 5-year period.
RESULTS: Isoflurane resulted in an improvement in arterial pH and a reduction in partial pressure of arterial carbon dioxide (PaCO(2)) in all the 11 instances. This effect was sustained in 10 cases and led to clinical improvement and rapid weaning from mechanical ventilation. One child failed to show sustained response and was placed on veno-venous extracorporeal membrane oxygenation. One child died secondary to anoxic brain injury sustained prior to hospitalization. Hypotension was the major side effect, and occurred in 8 children necessitating vasopressor support.
CONCLUSIONS: Isoflurane improves arterial pH and reduces partial pressure of arterial carbon dioxide in mechanically ventilated children with life-threatening status asthmaticus who are not responsive to conventional management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16614808     DOI: 10.1007/s00134-006-0163-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  24 in total

1.  Therapeutic options for severe, refractory status asthmaticus: inhalational anaesthetic agents, extracorporeal membrane oxygenation and helium/oxygen ventilation.

Authors:  J D Tobias; J S Garrett
Journal:  Paediatr Anaesth       Date:  1997       Impact factor: 2.556

2.  Surveillance for asthma--United States, 1960-1995.

Authors:  D M Mannino; D M Homa; C A Pertowski; A Ashizawa; L L Nixon; C A Johnson; L B Ball; E Jack; D S Kang
Journal:  MMWR CDC Surveill Summ       Date:  1998-04-24

3.  The effect of isoflurane, halothane, sevoflurane, and thiopental/nitrous oxide on respiratory system resistance after tracheal intubation.

Authors:  G A Rooke; J H Choi; M J Bishop
Journal:  Anesthesiology       Date:  1997-06       Impact factor: 7.892

4.  Status asthmaticus treated with isoflurane and enflurane.

Authors:  S M Parnass; J M Feld; W H Chamberlin; L J Segil
Journal:  Anesth Analg       Date:  1987-02       Impact factor: 5.108

5.  Prolonged isoflurane anesthesia in a case of catastrophic asthma.

Authors:  T Miyagi; Y Gushima; T Matsumoto; K Okamoto; T Miike
Journal:  Acta Paediatr Jpn       Date:  1997-06

6.  Mechanical ventilation in children with severe asthma.

Authors:  K Malmström; M Kaila; K Korhonen; T Dunder; M Nermes; T Klaukka; S Sarna; K Juntunen-Backman
Journal:  Pediatr Pulmonol       Date:  2001-06

7.  Noninvasive positive-pressure ventilation in pediatric status asthmaticus.

Authors:  Olugbenga A. Akingbola; Narong Simakajornboon; Edwin F. Hadley Jr; Robert L. Hopkins
Journal:  Pediatr Crit Care Med       Date:  2002-04       Impact factor: 3.624

8.  Isoflurane therapy for status asthmaticus in children and adults.

Authors:  R G Johnston; T W Noseworthy; E G Friesen; H A Yule; A Shustack
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

9.  Isoflurane in the treatment of asthma.

Authors:  S Revell; D Greenhalgh; S R Absalom; N Soni
Journal:  Anaesthesia       Date:  1988-06       Impact factor: 6.955

Review 10.  The pharmacology of isoflurane.

Authors:  E I Eger
Journal:  Br J Anaesth       Date:  1984       Impact factor: 9.166

View more
  19 in total

1.  Impairment of Venous Drainage on Extracorporeal Membrane Oxygenation Secondary to Air Trapping in Acute Asphyxial Asthma.

Authors:  Kevin S Niimi; Leslie S Lewis; Jeffrey J Fanning
Journal:  J Extra Corpor Technol       Date:  2015-06

2.  Peak pressures or plateau pressures in acute asthma.

Authors:  Ritesh Agarwal; Alok Nath
Journal:  Intensive Care Med       Date:  2006-10-26       Impact factor: 17.440

3.  [Functioning of the anaesthetic conserving device: aspects to consider for use in inhalational sedation].

Authors:  A Meiser; M Bellgardt; H Vogelsang; C Sirtl; T Weber
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

4.  [AnaConDa].

Authors:  C Sirtl; H Laubenthal; A Meiser
Journal:  Anaesthesist       Date:  2007-12       Impact factor: 1.041

Review 5.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

6.  [Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system].

Authors:  J Kompardt; K Schärff; K Kubosch; C Pohl; M Bomplitz; J Soukup
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

7.  Ten common questions (and their answers) about off-label drug use.

Authors:  Christopher M Wittich; Christopher M Burkle; William L Lanier
Journal:  Mayo Clin Proc       Date:  2012-08-06       Impact factor: 7.616

8.  [Severe exacerbation of COPD requiring ventilation : Use of vv‑ECMO combined with inhalation anesthetics].

Authors:  M Laufenberg; T Schneider
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-08-16       Impact factor: 0.840

9.  Targeted Versus Continuous Delivery of Volatile Anesthetics During Cholinergic Bronchoconstriction.

Authors:  Jarred R Mondoñedo; John S McNeil; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  J Eng Sci Med Diagn Ther       Date:  2018-05-09

10.  Volatile Anesthetics and the Treatment of Severe Bronchospasm: A Concept of Targeted Delivery.

Authors:  Jarred R Mondoñedo; John S McNeil; Samir D Amin; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.